| PRU |
Report |
Adjusted operating EPS (Q2'26) |
BEAT |
pred ~$3.48 vs. cons $3.38 |
MEDIUM |
| PRU |
Report |
PGIM total AUM (6/30/26) |
BEAT |
pred ~$1.49T vs. cons ~$1.45T |
HIGH |
| PRU |
Report |
International (Japan) segment AOI — Japan suspension drag building sequentially |
MISS |
pred ~$650M vs. cons ~$710M |
LOW |
| PRU |
Guide |
Long-term strategy reveal — ROE/margin target (the true catalyst; high bar into print) |
UNKNOWN |
guide ~14-15% ROE target vs. cons/current ~13% (multi-year, 2028) |
LOW |
| PRU |
Guide |
FY2026 Japan/POJ AOI drag (suspension through Nov 5, non-linear/building) |
UNCHANGED |
guide ~$525-575M vs. cons ~$550M (FY2026) |
MEDIUM |
| PRU |
Guide |
Capital return / buyback pace (potential step-up as part of strategy) |
UNKNOWN |
guide ~$1.0B buyback vs. cons ~$1.0B (FY2026) |
LOW |
| PRU |
Guide |
PGIM operating margin (~$100M cost saves / 200bp expansion target) |
UNCHANGED |
guide ~20-21% vs. cons ~20% (FY2026, LT goal 25-30%) |
LOW |
| PRU |
Return |
Day-1 residual (stock − beta × S&P 500) |
-2.0% |
— |
MEDIUM |
| PRU |
Return |
5-day cumulative residual |
-3.5% (FADE) |
Classic buy-the-rumor/sell-the-news: stock is up ~23% in two months and ~8% since the 7/15 pre-announcement, sitting at 52-week highs, so the strategy reveal has to be genuinely bold to justify the run-up. The quarter itself carries little surprise (assumption review, PGIM AUM, alts all pre-disclosed), so the print is a non-event while the out-period math is negative: in-force earnings guided down ~10% in 2026 / ~15% in 2027, Japan drag builds through the year, and ROE/margin targets are long-dated. A 'tweaks-only' strategy or targets viewed as too far out pulls estimates and multiple back, driving profit-taking after the rally — hence fade rather than follow-through. |
MEDIUM |